Latest AI and machine learning research in dementia for healthcare professionals.
Purpose: The primary goal of this study is to explore the application of evaluation metrics to different clustering algorithms using the data provided from the Canadian Longitudinal Study (CLSA), focusing on cognitive features. The objective of our work is to discover potential clinically relevant clusters that contribute to the development of dementia over time-based on cognitive changes. Metho...
Alzheimer's disease (AD) leads to progressive cognitive decline, making early detection crucial for effective intervention. While deep learning models have shown high accuracy in AD diagnosis, their lack of interpretability limits clinical trust and adoption. This paper introduces a novel pre-model approach leveraging Jacobian Maps (JMs) within a multi-modal framework to enhance explainability a...
Large language models (LLMs) have emerged as powerful tools for medical information retrieval, yet their accuracy and depth remain limited in specia...
The need to improve geriatric care quality presents a challenge that requires insights from stakeholders. While simulated trainings can boost compet...
Previous research has established type 2 diabetes mellitus as a significant risk factor for various disorders, adversely impacting human health. While...
Alzheimer's Disease is a progressive neurological disorder that is one of the most common forms of dementia. It leads to a decline in memory, reason...
The causal relationships between biomarkers are essential for disease diagnosis and medical treatment planning. One notable application is Alzheimer...
Alzheimer's Disease (AD) is a progressive neurodegenerative disorder that poses significant diagnostic challenges due to its complex etiology. Graph...
Given the relationship between hippocampal atrophy and cognitive impairment in various pathological conditions, hippocampus segmentation from MRI is a...
The progression of Alzheimer's disease (AD) involves complex changes in brain structure and function that are driven by their interaction, making stru...
Machine learning has been successfully used in critical domains, such as medicine. However, extracting meaningful insights from biomedical data is o...
Alzheimer's Disease (AD) dementia is a progressive neurodegenerative disease that negatively impacts patients' cognitive ability. Previous studies h...
Alzheimer's disease and related dementias (AD/ADRD) represent a growing healthcare crisis affecting over 6 million Americans. While genetic factors ...
The accurate diagnosis of Alzheimer's disease (AD) and prognosis of mild cognitive impairment (MCI) conversion are crucial for early intervention. H...
Retinal optical coherence tomography (OCT) images are the biomarkers for neurodegenerative diseases, which are rising in prevalence. Early detection...
Alzheimer's disease, a neurodegenerative disorder, is associated with neural, genetic, and proteomic factors while affecting multiple cognitive and ...
Alzheimer's disease (AD) is a major neurodegenerative condition that affects millions around the world. As one of the main biomarkers in the AD diag...
The Lewy body dementia (LBD) is the second most common neurodegenerative dementia after Alzheimer's disease (AD). Early differentiation between AD a...
Dementia is a progressive condition that impairs an individual's cognitive health and daily functioning, with mild cognitive impairment (MCI) often ...
Dementia, a neurological disorder impacting millions globally, presents significant challenges in diagnosis and patient care. With the rise of priva...